Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Luque

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
European Urology|April 15, 2004
Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1)A Lopez-Beltran, R J Luque, J Alvarez-Kindelan, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Correction: de Salazar et al. Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation. <i>Antioxidants</i> 2020, <i>9</i>, 1145Lydia de Salazar, Carlos Contreras, Antonio Torregrosa-García, et al.
Experimental Gerontology|January 29, 2013
Effects of high-resistance circuit training in an elderly populationSalvador Romero-Arenas, Anthony J Blazevich, Miryam Martínez-Pascual, et al.
Antioxidants (Basel, Switzerland)|November 21, 2020
Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA SupplementationLydia de Salazar, Carlos Contreras, Antonio Torregrosa-García, et al.
International Journal of Obesity (2005)|October 15, 2014
Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: A randomized, crossover trialC Bandín, F A J L Scheer, A J Luque, et al.
The Journal of Pathology|May 3, 2008
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urotheliumA Lopez-Beltran, J Alvarez-Kindelan, R J Luque, et al.
Cancer Letters|January 24, 2006
Apoptotic and proliferation indexes in primary superficial bladder tumorsRicardo Gonzalez-Campora, Guillermo Davalos-Casanova, Antonio Beato-Moreno, et al.
Bioorganic & Medicinal Chemistry|September 15, 2009
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological toolsDaniel I Perez, Santiago Conde, Concepción Pérez, et al.
The Journal of Pathology|February 17, 2006
Cyclin D3 expression in primary Ta/T1 bladder cancerA Lopez-Beltran, M J Requena, R J Luque, et al.
Journal of Medicinal Chemistry|December 2, 2000
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's diseaseP Camps, El Achab R, J Morral, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
European Urology|April 15, 2004
Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1)A Lopez-Beltran, R J Luque, J Alvarez-Kindelan, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Correction: de Salazar et al. Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation. <i>Antioxidants</i> 2020, <i>9</i>, 1145Lydia de Salazar, Carlos Contreras, Antonio Torregrosa-García, et al.
Experimental Gerontology|January 29, 2013
Effects of high-resistance circuit training in an elderly populationSalvador Romero-Arenas, Anthony J Blazevich, Miryam Martínez-Pascual, et al.
Antioxidants (Basel, Switzerland)|November 21, 2020
Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA SupplementationLydia de Salazar, Carlos Contreras, Antonio Torregrosa-García, et al.
International Journal of Obesity (2005)|October 15, 2014
Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: A randomized, crossover trialC Bandín, F A J L Scheer, A J Luque, et al.
The Journal of Pathology|May 3, 2008
Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urotheliumA Lopez-Beltran, J Alvarez-Kindelan, R J Luque, et al.
Cancer Letters|January 24, 2006
Apoptotic and proliferation indexes in primary superficial bladder tumorsRicardo Gonzalez-Campora, Guillermo Davalos-Casanova, Antonio Beato-Moreno, et al.
Bioorganic & Medicinal Chemistry|September 15, 2009
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological toolsDaniel I Perez, Santiago Conde, Concepción Pérez, et al.
The Journal of Pathology|February 17, 2006
Cyclin D3 expression in primary Ta/T1 bladder cancerA Lopez-Beltran, M J Requena, R J Luque, et al.
Journal of Medicinal Chemistry|December 2, 2000
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's diseaseP Camps, El Achab R, J Morral, et al.
Pageof 21